|Articles|March 1, 2017
- BioPharm International-03-01-2017
- Volume 30
- Issue 3
BioPharm International, March 2017 Issue (PDF)
Click the title above to open the BioPharm International March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Automating Bioprocessesover 8 years ago
Biosimilar Names Prove Difficult to Defineover 8 years ago
Strategizing a Shortcut to Marketover 8 years ago
Covering Global Regulations in a Quality Systemover 8 years ago
Will Pharma Manufacturing Move Back to the US?over 8 years ago
Serialization Hits the Home Stretchover 8 years ago
Harnessing Advances in Informatics to Ensure Data Integrityover 8 years ago
Being Thorough When Transferring TechnologyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
